Knowledge Center

Article / Jan 01, 2011

What is Special About Inhalation APIs?

Authors:
  • Carla Vozone
Source:
Drug Development and Delivery, January 2011

What is Special About Inhalation APIs? Drug Development Executive: Carla Vozone, Director of Business Development for Hovione's Generics Business Unit, discusses what makes Hovione unique in API supply for inhalation, its supportive technologies, and approach to the market.

Related links

Read article here

Also in the Knowledge Center

Related Content

Procurement

We partner, connect and align to shape supplier solutions that help Hovione reach its growth and objectives.

Page
Read more

Drug Product Development

Leveraging our expertise particle engineering, Hovione can now develop oral dosage forms and inhaled dosages forms to offer dependable solutions for complex drug products.

Page
Read more

Analytical Characterization

Hovione advanced characterization capabilities of inhalation and nasal products is crucial to determine their safety and efficacy.

Page
Read more